Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European organisation for research and treatment of cancer randomized trial 40954

Journal of Clinical Oncology

Volumn 28, Issue 35, 2010, Pages 5210-5218

  Schuhmacher, Christoph ^a   Gretschel, Stephan ^a   Lordick, Florian ^a   Reichardt, Peter ^a   Hohenberger, Werner ^a   Eisenberger, Claus F ^a   Haag, Cornelie ^a   Mauer, Murielle E ^a   Hasan, Baktiar ^a   Welch, John ^a   Ott, Katja ^a   Hoelscher, Arnulf ^a   Schneider, Paul M ^a   Bechstein, Wolf ^a   Wilke, Hans ^a   Lutz, Manfred P ^a   Nordlinger, Bernard ^a   Van Cutsem, Eric ^a   Siewert, Jörg R ^a   Schlag, Peter M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CARDIA CARCINOMA; CARDIOTOXICITY; CONTINUOUS INFUSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ADENOCARCINOMA; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARDIA; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; STOMACH NEOPLASMS;

EID: 79951904022     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.6114     Document Type: Article

References (22)

1. Chau I, Norman AR, Cunningham D, et al: Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer: Pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22:2395-2403, 2004 (Pubitemid 41121931)
2. Siewert JR, Bottcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer study. Ann Surg 228:449-461, 1998 (Pubitemid 30194389)
3. Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. Cancer J Clin 50:7-33, 2000
4. Roder JD, Böttcher K, Siewert JR: Prognostic factors in gastric carcinoma: Results of the German Gastric Carcinoma study 1992. Cancer 72:2089-2097, 1993
5. Paoletti X, Oba K, Burzykowski T, et al: Benefit of adjuvant chemotherapy for resectable gastric cancer: A meta-analysis. JAMA 303:1729-1737, 2010
6. Cunningham D, Allum WH, Stenning SP, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20, 2006
7. Boige V, Pignon J, Saint-Aubret B, et al: Final results of a randomized trial comparing preoperative 5-fluorouracil (F)/cisplatin (P) to surgery alone in adenocarcinoma of stomach and lower esophagus (ASLE): FNLCC ACCORD07-FFCD 9703 trial. J Clin Oncol 25:200s, 2007 (suppl; abstr 4510)
8. Lutz M, Wilke H, Wagener DJT, et al: Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: Randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 25:2580-2585, 2007 (Pubitemid 47044813)
9. Feussner H, Fink U, Walker SL, et al: Preoperative laparoscopic staging in advanced gastric carcinoma, in Nishi M, Sugano H, Takahashi I (eds): First International Gastric Cancer Congress, Kyoto, 1995. Bologna, Italy, Monduzzi, 1995, pp 82-87
10. Stein HJ, Feith M, Siewert JR: Cancer of the esophagogastric junction. Surg Oncol 9:35-41, 2000
11. Feussner H, Omote K, Fink U, et al: Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy 31:342-347, 1999 (Pubitemid 29319800)
12. Ott K, Sendler A, Becker K, et al: Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: A prospective phase II study. Gastric Cancer 6:159-167, 2003 (Pubitemid 37221566)
13. Volpe CM, Driscoll DL, Douglass HO Jr: Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes. Ann Surg Oncol 7:139-144, 2000 (Pubitemid 30164683)
14. Sobin LH, Wittekind C: International Union Against Cancer: TNM Classification of Malignant Tumors (ed 5). New York, NY, Wiley-Liss, 1997
15. National Cancer Institute Common Toxicity Criteria, Version 2.0: Cancer Therapy Evaluation Program, 1998. http://ctep.cancer.gov/protocolDevelopment/ electronic-applications/docs/ctcv20-4-30-992.pdf
16. Allum WH, Stenning SP, Bancewicz PI, et al: Long term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 27:5062-5066, 2009
17. Wilke H, Korn M, Vanhöfer U, et al: Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer. J Infus Chemother 6:123-126, 1996
18. Menges M, Schmidt C, Lindemann W, et al: Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol 129:423-429, 2003 (Pubitemid 37006397)
19. Fink U, Schuhmacher C, Stein HJ, et al: Preoperative chemotherapy for stage III-IV gastric carcinoma: Feasibility, response and outcome after complete resection. Br J Surg 82:1248-1252, 1995
20. Al-Batran SE, Hartman JT, Probst S, et al: Phase III trial in metastatic gastroeosphageal adenocarcinoma with flurouracil, leucovorin plus either oxaliplatin or cisplatin: A study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435-1442, 2008
21. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
22. Dutch Colorectal Cancer Group: A multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer (CRITICS study). ClinicalTrials.gov Identifier NCT00407186. http://clinicaltrials.gov/ct2/show/ NCT00407186